Explore
Trendline
GI Partners Acquires CDMO and Cell Solutions from Charles River, Forms Rose BioSolutions
GI Partners Acquires CDMO and Cell Solutions from Charles River, Forms Rose BioSolutions
Read More
Trendline
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Read More
Trendline
Charles River Laboratories Reports First-Quarter 2026 Results with Revenue Increase and Stock Repurchase
Charles River Laboratories Reports First-Quarter 2026 Results with Revenue Increase and Stock Repurchase
Read More
Trendline
Lilly Invests $4.5 Billion in Indiana Manufacturing, Opens Genetic Medicine Facility
Lilly Invests $4.5 Billion in Indiana Manufacturing, Opens Genetic Medicine Facility
Read More
Trendline
Digital Orchestration Transforms Regulatory Frameworks for Cell and Gene Therapy
Digital Orchestration Transforms Regulatory Frameworks for Cell and Gene Therapy
Read More
Trendline
Biotech R Job Postings Surge Amid Improved Capital Environment
Biotech R Job Postings Surge Amid Improved Capital Environment
Read More
Trendline
Bracco Imaging Introduces BubbleGen Early Access Program for Cell Therapy Innovation
Bracco Imaging Introduces BubbleGen Early Access Program for Cell Therapy Innovation
Read More
Trendline
Thermo Fisher Scientific Launches New Bioreactor for Scalable Cell Therapy Manufacturing
Thermo Fisher Scientific Launches New Bioreactor for Scalable Cell Therapy Manufacturing
Read More
Trendline
Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy
Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy
Read More
Trendline
Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing
Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing
Read More
Trendline
Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting
Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting
Read More
Trendline
Merck Completes Acquisition of Terns Pharmaceuticals, Expanding Oncology Pipeline
Merck Completes Acquisition of Terns Pharmaceuticals, Expanding Oncology Pipeline
Read More